Myriad Genetics (Weighted Average Cost of Capital (WACC) Analysis)
 Improve your investment analysis with by seeing the Myriad Genetics's Discounted Cash Flow analysis, Myriad Genetics's Warren Buffet analysis, and Myriad Genetics's Comparable Multiple analysis.  Helpful Information for Myriad Genetics's AnalysisWhat is the WACC Formula? Analyst use the WACC Discount Rate (weighted average cost of capital) to determine Myriad Genetics's investment risk. WACC Formula = Cost of Equity (CAPM) * Common Equity + (Cost of Debt) * Total Debt. The result of this calculation is an essential input for the discounted cash flow (DCF) analysis for Myriad Genetics. Value Investing Importance? This method is widely used by investment professionals to determine the correct price for investments in Myriad Genetics before they make value investing decisions. This WACC analysis is used in Myriad Genetics's discounted cash flow (DCF) valuation and see how the WACC calculation affect's Myriad Genetics's company valuation. |
WACC Analysis Information1. The WACC (discount rate) calculation for Myriad Genetics uses comparable companies to produce a single WACC (discount rate). An industry average WACC (discount rate) is the most accurate for Myriad Genetics over the long term. If there are any short-term differences between the industry WACC and Myriad Genetics's WACC (discount rate), then Myriad Genetics is more likely to revert to the industry WACC (discount rate) over the long term. 2. The WACC calculation uses the higher of Myriad Genetics's WACC or the risk free rate, because no investment can have a cost of capital that is better than risk free. This situation may occur if the beta is negative and Myriad Genetics uses a significant proportion of equity capital. |
